NOVEL MONOCLONAL ANTIBODIES TO OSTEOPONTIN
The present disclosure relates to the development of antibodies that are targeted to disease specific function directing regions of osteopontin. Such antibodies are capable of binding osteopontin and of selectively blocking one or more functions of osteopontin. In one aspect, the disclosures are bas...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | MCKEARN, John P BLITZER, Jeremy |
| description | The present disclosure relates to the development of antibodies that are targeted to disease specific function directing regions of osteopontin. Such antibodies are capable of binding osteopontin and of selectively blocking one or more functions of osteopontin. In one aspect, the disclosures are based on the discovery that such antibodies spontaneously occur in certain diseases, and have therapeutic utility for the treatment of one or more osteopontin related diseases, where they are capable of selectively blocking the role of osteopontin in disease progression. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2019367602A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2019367602A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2019367602A13</originalsourceid><addsrcrecordid>eNrjZNDy8w9z9VHw9ffzd_bx93P0UXD0C_F08nfxdA1WCPFX8A8OcfUP8AeK-fEwsKYl5hSn8kJpbgZlN9cQZw_d1IL8-NTigsTk1LzUkvjQYCMDQ0tjM3MzAyNHQ2PiVAEABSQl6g</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>NOVEL MONOCLONAL ANTIBODIES TO OSTEOPONTIN</title><source>esp@cenet</source><creator>MCKEARN, John P ; BLITZER, Jeremy</creator><creatorcontrib>MCKEARN, John P ; BLITZER, Jeremy</creatorcontrib><description>The present disclosure relates to the development of antibodies that are targeted to disease specific function directing regions of osteopontin. Such antibodies are capable of binding osteopontin and of selectively blocking one or more functions of osteopontin. In one aspect, the disclosures are based on the discovery that such antibodies spontaneously occur in certain diseases, and have therapeutic utility for the treatment of one or more osteopontin related diseases, where they are capable of selectively blocking the role of osteopontin in disease progression.</description><language>eng</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES ; MEASURING ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; ORGANIC CHEMISTRY ; PEPTIDES ; PHYSICS ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPIRITS ; TESTING ; VINEGAR ; WINE</subject><creationdate>2019</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20191205&DB=EPODOC&CC=US&NR=2019367602A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20191205&DB=EPODOC&CC=US&NR=2019367602A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>MCKEARN, John P</creatorcontrib><creatorcontrib>BLITZER, Jeremy</creatorcontrib><title>NOVEL MONOCLONAL ANTIBODIES TO OSTEOPONTIN</title><description>The present disclosure relates to the development of antibodies that are targeted to disease specific function directing regions of osteopontin. Such antibodies are capable of binding osteopontin and of selectively blocking one or more functions of osteopontin. In one aspect, the disclosures are based on the discovery that such antibodies spontaneously occur in certain diseases, and have therapeutic utility for the treatment of one or more osteopontin related diseases, where they are capable of selectively blocking the role of osteopontin in disease progression.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</subject><subject>MEASURING</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PHYSICS</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPIRITS</subject><subject>TESTING</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2019</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNDy8w9z9VHw9ffzd_bx93P0UXD0C_F08nfxdA1WCPFX8A8OcfUP8AeK-fEwsKYl5hSn8kJpbgZlN9cQZw_d1IL8-NTigsTk1LzUkvjQYCMDQ0tjM3MzAyNHQ2PiVAEABSQl6g</recordid><startdate>20191205</startdate><enddate>20191205</enddate><creator>MCKEARN, John P</creator><creator>BLITZER, Jeremy</creator><scope>EVB</scope></search><sort><creationdate>20191205</creationdate><title>NOVEL MONOCLONAL ANTIBODIES TO OSTEOPONTIN</title><author>MCKEARN, John P ; BLITZER, Jeremy</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2019367602A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2019</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</topic><topic>MEASURING</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PHYSICS</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPIRITS</topic><topic>TESTING</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>MCKEARN, John P</creatorcontrib><creatorcontrib>BLITZER, Jeremy</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>MCKEARN, John P</au><au>BLITZER, Jeremy</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>NOVEL MONOCLONAL ANTIBODIES TO OSTEOPONTIN</title><date>2019-12-05</date><risdate>2019</risdate><abstract>The present disclosure relates to the development of antibodies that are targeted to disease specific function directing regions of osteopontin. Such antibodies are capable of binding osteopontin and of selectively blocking one or more functions of osteopontin. In one aspect, the disclosures are based on the discovery that such antibodies spontaneously occur in certain diseases, and have therapeutic utility for the treatment of one or more osteopontin related diseases, where they are capable of selectively blocking the role of osteopontin in disease progression.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_US2019367602A1 |
| source | esp@cenet |
| subjects | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PHYSICS PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPIRITS TESTING VINEGAR WINE |
| title | NOVEL MONOCLONAL ANTIBODIES TO OSTEOPONTIN |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T10%3A05%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=MCKEARN,%20John%20P&rft.date=2019-12-05&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2019367602A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |